Company Valuation: MetLife, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 42,253 52,564 56,782 48,949 56,695 50,052 50,052 -
Change - 24.4% 8.02% -13.8% 15.83% -11.72% 0% -
Enterprise Value (EV) 42,253 52,564 76,220 56,093 56,695 50,052 50,052 50,052
Change - 24.4% 45% -26.41% 1.07% -11.72% 0% 0%
P/E ratio 8.27x 8.55x 24.9x 36.5x 13.8x 16.8x 8.41x 7.56x
PBR 0.6x 0.81x 2.43x 1.84x 2.39x 2.02x 1.69x 1.5x
PEG - 0.3x -0.4x -1x 0x -0.8x 0.1x 0.7x
Capitalization / Revenue 0.64x 0.75x 0.75x 0.68x 0.78x 0.66x 0.64x 0.61x
EV / Revenue 0x 0x 0x 0x 0x 0.59x 0.64x 0.61x
EV / EBITDA - - - - - - - -
EV / EBIT 0x 0x 0x 0x - 5.55x 4.92x 4.63x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 1.82 1.9 1.98 2.06 2.155 2.246 2.352 2.458
Rate of return 3.88% 3.04% 2.74% 3.12% 2.63% 2.94% 3.08% 3.22%
EPS 2 5.68 7.31 2.91 1.81 5.94 4.71 9.083 10.1
Distribution rate 32% 26% 68% 114% 36.3% 38.9% 25.9% 24.3%
Net sales 1 66,465 70,244 75,548 71,715 73,051 78,840 78,355 81,478
EBITDA - - - 9,080 - - - -
EBIT 1 8,120 11,000 8,221 8,362 - 9,087 10,166 10,816
Net income 1 5,191 6,353 2,354 1,380 4,226 3,173 5,927 6,331
Net Debt - - 19,438 7,144 - - - -
Reference price 2 46.95 62.49 72.37 66.13 81.88 76.38 76.38 76.38
Nbr of stocks (in thousands) 899,949 841,160 784,606 740,190 692,420 655,300 655,300 -
Announcement Date 03/02/21 02/02/22 01/02/23 31/01/24 05/02/25 04/02/26 - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
13.24x - - 2.94% 50.05B
8.43x5.28x - 4.1% 169B
9.01x0.87x - 5.85% 93.9B
15.82x - - 3.38% 63.88B
12.86x0.96x - 4.41% 63.26B
20x3.05x - 1.98% 60.76B
8.45x0.99x - 2.66% 57.89B
14.16x - - 3.95% 40.77B
14.5x - - 1.65% 40.62B
13.41x - - 3.95% 36.12B
Average 12.99x 2.23x 3.49% 67.64B
Weighted average by Cap. 12.00x 2.87x 3.74%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. MET Stock
  4. Valuation MetLife, Inc.